Picture of Veracyte logo

VCYT — Veracyte News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Veracyte Inc reports results for the quarter ended in December - Earnings Summary

* Veracyte Inc  VCYT.OQ  reported a quarterly adjusted loss
of 15
cents​​ per share for the quarter ended in December. The mean
expectation of ten analysts for the quarter was for a loss of 15
cents per share.
    * Revenue rose 95% to $67.34 million from a year ago; 
analysts
expected $61.79 million. 
    * The mean earnings estimate of analysts had risen by
about 0.4%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Veracyte Inc shares had fallen by 34.6% this quarter.
    * The company reported a quarterly loss of $10.53 million.
    * Wall Street's median 12-month price target for Veracyte
Inc is
$53.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated March 1 at 12:06 a.m.  ​All
figures in US dollars unless otherwise stated

Recent news on Veracyte

See all news